Wratil, Paul R.
Stern, Marcel http://orcid.org/0000-0002-7692-6905
Priller, Alina http://orcid.org/0000-0002-4982-0347
Willmann, Annika
Almanzar, Giovanni
Vogel, Emanuel http://orcid.org/0000-0001-6560-0136
Feuerherd, Martin http://orcid.org/0000-0002-5272-6503
Cheng, Cho-Chin
Yazici, Sarah
Christa, Catharina
Jeske, Samuel
Lupoli, Gaia http://orcid.org/0000-0002-2786-6627
Vogt, Tim
Albanese, Manuel http://orcid.org/0000-0002-4614-7599
Mejías-Pérez, Ernesto http://orcid.org/0000-0002-5208-8177
Bauernfried, Stefan http://orcid.org/0000-0003-1910-5032
Graf, Natalia
Mijocevic, Hrvoje
Vu, Martin
Tinnefeld, Kathrin
Wettengel, Jochen
Hoffmann, Dieter
Muenchhoff, Maximilian http://orcid.org/0000-0001-7016-0470
Daechert, Christopher http://orcid.org/0000-0001-6441-3099
Mairhofer, Helga
Krebs, Stefan
Fingerle, Volker
Graf, Alexander
Steininger, Philipp
Blum, Helmut http://orcid.org/0000-0002-3994-2332
Hornung, Veit http://orcid.org/0000-0002-4150-194X
Liebl, Bernhard
Überla, Klaus
Prelog, Martina
Knolle, Percy http://orcid.org/0000-0003-2983-0414
Keppler, Oliver T. http://orcid.org/0000-0002-1384-8946
Protzer, Ulrike http://orcid.org/0000-0002-9421-1911
Funding for this research was provided by:
Helmholtz Association (CoViPa consortium)
Deutsche Forschungsgemeinschaft (TRR179)
Bavarian State Ministry of Science, FOR-Covid consortium and CoVaKo study
Article History
Received: 3 January 2022
Accepted: 25 January 2022
First Online: 28 January 2022
Competing interests
: The authors declare no competing interests concerning the study content. Outside the study, they declare the following competing interests: U.P. is a cofounder, shareholder and board member of SCG Cell Therapy, a member of the scientific advisory board of Leukocare and a member of topic-specific scientific advisory boards of Sanofi-Pasteur, GILEAD and GSK and an ad hoc advisor for BioNTech (without remuneration).
Free to read: This content has been made available to all.